Anbio Biotechnology shares fall 33.01% intraday as technical analysis signals 60.50% potential decline in three months.

Anbio Biotechnology plunged 33.01% intraday, driven by a recent 36.22% surge on November 11, 2025, and bearish technical analysis projecting a 60.50% decline over the next three months. The stock closed at $24.03 after three consecutive trading days of gains, with a 44.70% daily volatility.